News
"The outcome is correct, but it's disappointing that FINRA had ample opportunity to investigate the merits of clients' allegations in these claims, including the testimony in the three investor ...
Chuck Roberts ends a decadeslong career amid a flurry of client complaints.
Chuck Roberts, whose recommendations of structured notes landed the St. Louis firm a nearly $133 million arbitration award, ...
In the annual competition for best wealth management firm to work for, Stifel and Commonwealth again took home the gold.J.D.
Stifel maintained its 2027 AFFO estimate at $4.52 for Realty Income. The company previously guided 2025 AFFO between $4.22 ...
Vistagen Therapeutics, Inc. (NASDAQ:VTGN) is among the best growth stocks to invest in for the next 5 years. Analysts at Stifel reiterated their Buy rating on Vistagen Therapeutics, Inc.
In trading on Monday, shares of Stifel Financial Corporation's 4.50% Dep Shares Non-Cumulative Preferred Stock Series D (Symbol: SF.PRD) were yielding above the 6.5% mark based on its quarterly ...
Finance News LONDON BROKER RATINGS: Stifel cuts Bunzl; Investec raises Dialight LONDON BROKER RATINGS: Stifel cuts Bunzl; Investec raises Dialight 24th Jun 2025 09:22 (Alliance News) - The following ...
Stifel lands a team with $2.1 billion in AUM from Oppenheimer; Raymond James, UBS and LPL all log recruiting wins.
Hosted on MSN29d
Stifel Upgrades EPR Properties (EPR) - MSNFintel reports that on June 20, 2025, Stifel upgraded their outlook for EPR Properties (NYSE:EPR) from Hold to Buy. Analyst Price Forecast Suggests 3.92% Downside As of June 20, 2025, the average ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results